Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein

Area of Science:

• Hepatology
• Oncology
• Immunology

Background:

• Cellular interaction molecules may cause elevated alpha-fetoprotein (AFP) in non-neoplastic liver disease.
• Understanding AFP elevation in liver disease is crucial for distinguishing benign conditions from hepatocellular carcinoma.

Purpose of the Study:

• To investigate the relationship between AFP, circulating intercellular adhesion molecule 1 (cICAM-1), and liver function tests in patients with liver disease.
• To determine if cICAM-1 can predict non-specific AFP variations in non-neoplastic chronic liver disease.

Main Methods:

• Measured AFP, cICAM-1, and liver function tests in 111 patients (84 with non-neoplastic chronic liver disease, 27 with hepatocellular carcinoma).
• Utilized immunoenzymatic methods for cICAM-1 concentration determination.
• Performed univariate and multivariate analyses to identify predictors of AFP levels.

Main Results:

• In non-neoplastic chronic liver disease, AFP correlated significantly with cholinesterase, aspartate aminotransferase, bilirubin, and cICAM-1.
• Multivariate analysis identified cICAM-1 as the strongest independent predictor of AFP.
• cICAM-1 showed a stronger correlation with AFP than traditional liver function tests.

Conclusions:

• Circulating intercellular adhesion molecule 1 (cICAM-1) effectively predicts non-specific AFP variations in non-neoplastic chronic liver disease.
• The findings suggest a connection between inflammatory damage targeting hepatocytes and the potential development of liver neoplasia.
• cICAM-1 may serve as a valuable biomarker in managing liver disease and assessing cancer risk.